Noxopharm (ASX:NOX) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Noxopharm FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Noxopharm's Free Cash Flow for the six months ended in Dec. 2023 was A$2.14 Mil. Noxopharm's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, Noxopharm's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Noxopharm's current FCF Yield % is -30.72%.

The historical rank and industry rank for Noxopharm's FCF Margin % or its related term are showing as below:

ASX:NOX's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -145.04
* Ranked among companies with meaningful FCF Margin % only.

Noxopharm FCF Margin % Historical Data

The historical data trend for Noxopharm's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm FCF Margin % Chart

Noxopharm Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

Noxopharm Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Noxopharm's FCF Margin %

For the Biotechnology subindustry, Noxopharm's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Noxopharm's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Noxopharm's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Noxopharm's FCF Margin % falls into.

Noxopharm FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Noxopharm's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-10.946	/	0
	=	%

Noxopharm's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	2.138	/	0
	=	%

Noxopharm FCF Margin % Related Terms

Thank you for viewing the detailed overview of Noxopharm's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Noxopharm (ASX:NOX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

NOXOF:USA

Address

60 Linksley Ave, Glenhaven, NSW, AUS, 2156

Website

https://www.noxopharm.com

Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines